Affluent Medical S.A. | Small-cap | Healthcare
€1.61
-3.02%
| Affluent Medical Stock Comparison:
Affluent Medical vs Guerbet S.AAffluent Medical vs Eurobio ScientificAffluent Medical vs Median TechnologiesAffluent Medical vs Novacyt S.AAffluent Medical vs Theraclion S.AAffluent Medical vs CAC 40 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 60.9M
Total Liabilities 30.6M
Shareholders Equity 30.3M
Debt to Equity 1.01

Cash Flow Metrics

Revenue & Profitability Trend

Affluent Medical Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i4.1M0000
Cost of Goods Sold i3.3M2.1M2.4M2.5M3.1M
Gross Profit i856.0K-2.1M-2.4M-2.5M-3.1M
Gross Margin % i20.8%0.0%0.0%0.0%0.0%
Operating Expenses
Research & Development i94.0K72.0K52.0K23.0K9.0K
Selling, General & Administrative i163.0K149.0K152.0K1.2M69.0K
Other Operating Expenses i5.6M4.6M3.9M3.1M3.2M
Total Operating Expenses i5.8M4.8M4.1M4.3M3.3M
Operating Income i-14.6M-15.4M-14.3M-13.3M-12.6M
Operating Margin % i-355.4%0.0%0.0%0.0%0.0%
Non-Operating Items
Interest Income i---00
Interest Expense i516.0K409.0K710.0K3.1M2.2M
Other Non-Operating Income-----
Pre-tax Income i-14.9M-15.8M-15.4M-15.3M-14.5M
Income Tax i-142.0K-150.0K-173.0K-437.0K-209.0K
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-14.7M-15.7M-15.2M-14.8M-14.3M
Net Margin % i-357.9%0.0%0.0%0.0%0.0%
Key Metrics
EBITDA i-12.2M-13.0M-12.2M-10.8M-10.5M
EPS (Basic) i€-0.38€-0.51€-0.81€-0.88€-1.18
EPS (Diluted) i€-0.38€-0.51€-0.81€-0.88€-1.18
Basic Shares Outstanding i3916740930740373188865771687358212180441
Diluted Shares Outstanding i3916740930740373188865771687358212180441

Income Statement Trend

Affluent Medical Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i1.2M1.7M2.6M11.4M5.6M
Short-term Investments i5.4M----
Accounts Receivable i-----
Inventory i-----
Other Current Assets-----1.0K
Total Current Assets i12.2M5.8M7.2M14.7M7.9M
Non-Current Assets
Property, Plant & Equipment i235.0K892.0K213.0K283.0K247.0K
Goodwill i79.5M81.4M83.2M85.1M87.0M
Intangible Assets i15.1M17.0M18.8M20.7M22.6M
Long-term Investments-----
Other Non-Current Assets---1.0K-1.0K1.8M
Total Non-Current Assets i48.7M50.9M52.8M55.4M56.9M
Total Assets i60.9M56.7M60.0M70.0M64.8M
Liabilities
Current Liabilities
Accounts Payable i4.7M3.4M3.0M1.8M2.4M
Short-term Debt i1.7M1.8M2.1M2.8M3.8M
Current Portion of Long-term Debt-----
Other Current Liabilities30.0K37.0K108.0K270.0K438.0K
Total Current Liabilities i9.5M8.4M8.6M7.3M9.8M
Non-Current Liabilities
Long-term Debt i14.6M15.1M15.7M17.0M17.0M
Deferred Tax Liabilities i1.4M1.6M1.8M2.0M2.4M
Other Non-Current Liabilities-2.0K---55.2M2.0K
Total Non-Current Liabilities i21.1M16.7M17.6M19.2M19.8M
Total Liabilities i30.6M25.2M26.2M26.5M29.5M
Equity
Common Stock i3.9M3.1M20.8M18.2M15.3M
Retained Earnings i-70.9M-57.7M-70.6M-55.2M-42.6M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i30.3M31.5M33.8M43.5M35.3M
Key Metrics
Total Debt i16.3M16.8M17.7M19.8M20.8M
Working Capital i2.6M-2.6M-1.5M7.4M-1.9M

Balance Sheet Composition

Affluent Medical Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-14.7M-15.7M-15.2M-14.8M-14.3M
Depreciation & Amortization i-----
Stock-Based Compensation i778.0K731.0K146.0K42.0K959.0K
Working Capital Changes i-930.0K560.0K-1.4M-1.3M1.7M
Operating Cash Flow i-14.5M-14.0M-15.4M-13.3M-9.9M
Investing Activities
Capital Expenditures i-147.0K-171.0K-146.0K-334.0K-304.0K
Acquisitions i5.0M0---
Investment Purchases i-10.5M0---
Investment Sales i5.2M0---
Investing Cash Flow i-480.0K-171.0K-146.0K-160.0K-304.0K
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i000795.0K6.1M
Debt Repayment i-740.0K-866.0K-2.4M-5.2M-2.0M
Financing Cash Flow i11.7M11.7M2.9M19.1M13.7M
Free Cash Flow i-11.5M-12.2M-11.2M-12.7M-9.2M
Net Change in Cash i-3.2M-2.4M-12.6M5.6M3.5M

Cash Flow Trend

Affluent Medical Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -4.30
Forward P/E -1.52
Price to Book 1.95
Price to Sales 11.22

Profitability Ratios

Profit Margin -275.50%
Operating Margin -124.14%
Return on Equity -48.69%
Return on Assets -24.22%

Financial Health

Current Ratio 1.28
Debt to Equity 0.54
Beta 0.62

Per Share Data

EPS (TTM) €-0.41
Book Value per Share €0.79
Revenue per Share €0.11

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
afme60.0M-4.301.95-48.69%-275.50%0.54
Guerbet S.A 293.8M18.030.733.50%1.89%100.91
Eurobio Scientific 251.9M64.361.412.26%2.58%5.46
Median Technologies 91.7M-1.84-74.31%-109.93%-0.98
Novacyt S.A 34.8M-0.800.70-57.28%-212.73%24.81
Theraclion S.A 31.4M-5.58--203.90%-346.01%-66,510.16

Financial data is updated regularly. All figures are in the company's reporting currency.